EDGAR Filing Documents for 0001193125-23-004214

Form 8-K - Current report:

SEC Accession No. 0001193125-23-004214

Filing Date

2023-01-09

Accepted

2023-01-09 08:31:10

Documents

Period of Report

2023-01-09

Items

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d412017d8k.htm iXBRL	8-K	27044
2	EX-99.1	d412017dex991.htm	EX-99.1	25752
6	GRAPHIC	g412017ex99_1s10g1.jpg	GRAPHIC	401351
7	GRAPHIC	g412017ex99_1s11g1.jpg	GRAPHIC	130840
8	GRAPHIC	g412017ex99_1s12g1.jpg	GRAPHIC	275917
9	GRAPHIC	g412017ex99_1s13g1.jpg	GRAPHIC	292238
10	GRAPHIC	g412017ex99_1s14g1.jpg	GRAPHIC	325685
11	GRAPHIC	g412017ex99_1s15g1.jpg	GRAPHIC	234390
12	GRAPHIC	g412017ex99_1s16g1.jpg	GRAPHIC	465108
13	GRAPHIC	g412017ex99_1s17g1.jpg	GRAPHIC	346715
14	GRAPHIC	g412017ex99_1s18g1.jpg	GRAPHIC	366530
15	GRAPHIC	g412017ex99_1s19g1.jpg	GRAPHIC	306210
16	GRAPHIC	g412017ex99_1s1g1.jpg	GRAPHIC	211946
17	GRAPHIC	g412017ex99_1s20g1.jpg	GRAPHIC	118723
18	GRAPHIC	g412017ex99_1s2g1.jpg	GRAPHIC	434411
19	GRAPHIC	g412017ex99_1s3g1.jpg	GRAPHIC	329509
20	GRAPHIC	g412017ex99_1s4g1.jpg	GRAPHIC	325847
21	GRAPHIC	g412017ex99_1s5g1.jpg	GRAPHIC	135112
22	GRAPHIC	g412017ex99_1s6g1.jpg	GRAPHIC	301074
23	GRAPHIC	g412017ex99_1s7g1.jpg	GRAPHIC	199981
24	GRAPHIC	g412017ex99_1s8g1.jpg	GRAPHIC	132223
25	GRAPHIC	g412017ex99_1s9g1.jpg	GRAPHIC	318153
	Complete submission text file	0001193125-23-004214.txt		7969267

Data Files

Seq	Description	Document	Type	Size
3	XBRL TAXONOMY EXTENSION SCHEMA	akba-20230109.xsd	EX-101.SCH	2835
4	XBRL TAXONOMY EXTENSION LABEL LINKBASE	akba-20230109_lab.xml	EX-101.LAB	17235
5	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	akba-20230109_pre.xml	EX-101.PRE	10802
27	EXTRACTED XBRL INSTANCE DOCUMENT	d412017d8k_htm.xml	XML	3279

Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142

Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098

Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)